The Drug Enforcement Administration (DEA), a part of the Department of Justice, has announced a public hearing regarding a significant change in how marijuana is classified under federal law. The proposal seeks to reschedule marijuana from a Schedule I to a Schedule III substance under the Controlled Substances Act (CSA). This move, which has been driven by a growing recognition of marijuana’s medical applications, marks a critical juncture in the ongoing debate surrounding marijuana legislation in the United States. On May 21, 2024, the Department of Justice published a *Notice of Proposed Rulemaking* (NPRM) regarding the reclassification of marijuana. Currently classified as a Schedule I substance, marijuana is considered to have no accepted medical use and a high potential for abuse. However, the proposed reclassification would place marijuana in Schedule III, which reflects a substance with a lower potential for abuse and recognized medical uses. This decision is aligned with the Department of Health and Human Services’ (HHS) assessment that marijuana has a medically accepted use and a risk of abuse that is lower than that of substances in Schedules I and II. The rescheduling of marijuana from Schedule I to Schedule III is a monumental step for advocates of […]
The post Rescheduling of Marijuana: DEA’s Proposed Rulemaking and Hearing appeared first on Southern Maryland News Net.
Source: https://smnewsnet.comNew feed